Header Logo

Connection

Dusan Stefoski to Multiple Sclerosis

Back to Details
This is a "connection" page, showing publications Dusan Stefoski has written about Multiple Sclerosis.
Dusan Stefoski
Connection Strength
2.069
Multiple Sclerosis
  1. Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neurol. 2019 May; 6(5):923-931.
    View in: PubMed
    Score: 0.613
  2. A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study. Neurodegener Dis Manag. 2023 Oct; 13(5):261-268.
    View in: PubMed
    Score: 0.207
  3. Cyclophosphamide for severe acute forms of central nervous system inflammatory disorders. J Neurol Sci. 2023 08 15; 451:120693.
    View in: PubMed
    Score: 0.204
  4. Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study. Mult Scler. 2023 05; 29(6):719-730.
    View in: PubMed
    Score: 0.202
  5. Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study. J Neurol. 2020 Oct; 267(10):2851-2864.
    View in: PubMed
    Score: 0.166
  6. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology. 1996 Jul; 47(1):129-39.
    View in: PubMed
    Score: 0.127
  7. Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis? J Clin Neurosci. 2014 Dec; 21(12):2189-93.
    View in: PubMed
    Score: 0.111
  8. Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS. Neurology. 2011 Sep 06; 77(10):1020; author reply 1020.
    View in: PubMed
    Score: 0.091
  9. 4-Aminopyridine in multiple sclerosis: prolonged administration. Neurology. 1991 Sep; 41(9):1344-8.
    View in: PubMed
    Score: 0.091
  10. Freedom from disease activity in multiple sclerosis. Neurology. 2010 Apr 27; 74 Suppl 3:S3-7.
    View in: PubMed
    Score: 0.082
  11. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol. 2005 Jun; 62(6):860-4.
    View in: PubMed
    Score: 0.059
  12. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant. 1998 Mar; 21(6):537-41.
    View in: PubMed
    Score: 0.035
  13. Myogenic and central neurogenic factors in fatigue in multiple sclerosis. Mult Scler. 1996 Feb; 1(4):236-41.
    View in: PubMed
    Score: 0.031
  14. IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination. J Neuroimmunol. 2011 Apr; 233(1-2):147-59.
    View in: PubMed
    Score: 0.022
  15. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol. 1990 Feb; 27(2):186-92.
    View in: PubMed
    Score: 0.020
  16. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood. 1998 Nov 15; 92(10):3505-14.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.